Ken Fisher's REGN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 4,637 shares of Regeneron Pharmaceuticals, Inc. (REGN) worth $2.61 M, representing 0.00% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in REGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2019, adding 4,264 shares. Largest reduction occurred in Q1 2025, reducing 1,537 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Regeneron Pharmaceuticals (REGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Regeneron Pharmaceuticals (REGN) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +583 | New Buy | 583 | $360.21 |
| Q4 2014 | -59 | Reduce 10.12% | 524 | $410.31 |
| Q1 2015 | +10 | Add 1.91% | 534 | $451.31 |
| Q2 2015 | +31 | Add 5.81% | 565 | $509.73 |
| Q3 2015 | -61 | Reduce 10.80% | 504 | $464.29 |
| Q4 2015 | +111 | Add 22.02% | 615 | $543.09 |
| Q1 2016 | -2 | Reduce 0.33% | 613 | $406.20 |
| Q3 2016 | +7 | Add 1.14% | 620 | $401.61 |
| Q4 2016 | +95 | Add 15.32% | 715 | $366.43 |
| Q1 2017 | +91 | Add 12.73% | 806 | $387.10 |
| Q2 2017 | +605 | Add 75.06% | 1,411 | $491.14 |
| Q3 2017 | +163 | Add 11.55% | 1,574 | $447.27 |
| Q4 2017 | -109 | Reduce 6.93% | 1,465 | $376.11 |
| Q1 2018 | -135 | Reduce 9.22% | 1,330 | $344.36 |
| Q2 2018 | +250 | Add 18.80% | 1,580 | $344.94 |
| Q3 2018 | -302 | Reduce 19.11% | 1,278 | $403.76 |
| Q4 2018 | -14 | Reduce 1.10% | 1,264 | $373.42 |
| Q1 2019 | +4,264 | Add 337.34% | 5,528 | $410.64 |
| Q2 2019 | -99 | Reduce 1.79% | 5,429 | $312.95 |
| Q3 2019 | +18 | Add 0.33% | 5,447 | $277.40 |
| Q4 2019 | -159 | Reduce 2.92% | 5,288 | $375.57 |
| Q1 2020 | -145 | Reduce 2.74% | 5,143 | $488.24 |
| Q2 2020 | -2 | Reduce 0.04% | 5,141 | $623.61 |
| Q3 2020 | +130 | Add 2.53% | 5,271 | $559.86 |
| Q4 2020 | -44 | Reduce 0.83% | 5,227 | $483.07 |
| Q1 2021 | -112 | Reduce 2.14% | 5,115 | $473.12 |
| Q2 2021 | +44 | Add 0.86% | 5,159 | $558.64 |
| Q3 2021 | -85 | Reduce 1.65% | 5,074 | $605.24 |
| Q4 2021 | +142 | Add 2.80% | 5,216 | $631.52 |
| Q1 2022 | -650 | Reduce 12.46% | 4,566 | $698.42 |
| Q2 2022 | +3 | Add 0.07% | 4,569 | $591.16 |
| Q3 2022 | +50 | Add 1.09% | 4,619 | $688.89 |
| Q4 2022 | -13 | Reduce 0.28% | 4,606 | $721.67 |
| Q1 2023 | -239 | Reduce 5.19% | 4,367 | $821.67 |
| Q2 2023 | +1,001 | Add 22.92% | 5,368 | $718.54 |
| Q3 2023 | -218 | Reduce 4.06% | 5,150 | $823.10 |
| Q4 2023 | +472 | Add 9.17% | 5,622 | $878.35 |
| Q1 2024 | +192 | Add 3.42% | 5,814 | $962.54 |
| Q2 2024 | -149 | Reduce 2.56% | 5,665 | $1051.07 |
| Q3 2024 | -608 | Reduce 10.73% | 5,057 | $1051.32 |
| Q4 2024 | +833 | Add 16.47% | 5,890 | $712.51 |
| Q1 2025 | -1,537 | Reduce 26.10% | 4,353 | $634.37 |
| Q3 2025 | +284 | Add 6.52% | 4,637 | $562.41 |
Ken Fisher's Regeneron Pharmaceuticals Investment FAQs
Ken Fisher first purchased Regeneron Pharmaceuticals, Inc. (REGN) in Q3 2014, acquiring 583 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Regeneron Pharmaceuticals, Inc. (REGN) for 45 quarters since Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to Regeneron Pharmaceuticals, Inc. (REGN) was in Q1 2019, adding 5,528 shares worth $2.27 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 4,637 shares of Regeneron Pharmaceuticals, Inc. (REGN), valued at approximately $2.61 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Regeneron Pharmaceuticals, Inc. (REGN) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in Regeneron Pharmaceuticals, Inc. (REGN) was 5,890 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.